Novel therapeutic approach for pulmonary emphysema using gelatin microspheres releasing basic fibroblast growth factor in a canine model
- 292 Downloads
- 2 Citations
Abstract
Purposes
The prognosis of patients with emphysema is poor as there is no truly effective treatment. Our previous study showed that the alveolar space was smaller and the microvessel density was higher in a canine emphysema model after the intrapulmonary arterial administration of gelatin microspheres slowly releasing basic fibroblast growth factor (bFGF–GMS). In the present study, we evaluated the functional effect of injecting bFGF–GMS via the pulmonary artery in this canine pulmonary emphysema model.
Methods
Using the porcine pancreatic elastase (PPE)-induced total emphysema model, we approximated the value of lung compliance with a Power Lab System, and performed blood gas analysis in a control group, a total emphysema group, and a bFGF group in which bFGF–GMS were injected toward the whole pulmonary artery via the femoral vein. Each group comprised five dogs.
Results
Lung compliance was higher in the total emphysema group than in the control group (p = 0.031), and the bFGF group showed no significant improvement of lung compliance vs. the total emphysema group (p = 0.112). PaO2 (partial pressure of oxygen in arterial blood) was improved by administering bFGF–GMS in the total emphysema model (p = 0.027).
Conclusion
In the canine total emphysema model, blood gas parameters were improved by the whole pulmonary arterial administration of bFGF–GMS. This method has the potential to be an effective novel therapy for pulmonary emphysema.
Keywords
Emphysema Lung Pulmonary functionNotes
Conflict of interest
Sung Soo Chang and the co-authors have no conflicts of interest.
References
- 1.Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003;290:2301–12.PubMedCrossRefGoogle Scholar
- 2.Fan VS, Bryson CL, Curtis JR, Fihn SD, Bridevaux PO, McDonell MB, et al. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med. 2003;168:1488–94.PubMedCrossRefGoogle Scholar
- 3.Kaiwa Y, Kurokawa Y, Ando K, Nakagawa A, Mitsui K, Miki H, et al. Correlation of unilateral thoracoscopic lung volume reduction with improvement in lung function and exercise performance in patients with severe pulmonary emphysema. Surg Today. 1999;29:718–23.PubMedCrossRefGoogle Scholar
- 4.Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev. 1987;8:95–114.PubMedCrossRefGoogle Scholar
- 5.Baird A, Ueno N, Esch F, Ling N. Distribution of fibroblast growth factors (FGFs) in tissues and structure–function studies with synthetic fragments of basic FGF. J Cell Physiol Suppl. 1987;5:101–6.PubMedCrossRefGoogle Scholar
- 6.Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.PubMedCrossRefGoogle Scholar
- 7.Okamoto T, Yamamoto Y, Gotoh M, et al. Cartilage regeneration using slow release of bone morphogenetic protein-2 from a gelatin sponge to treat experimental canine tracheomalacia: a preliminary report. ASAIO J. 2003;49:63–9.PubMedCrossRefGoogle Scholar
- 8.Okamoto T, Yamamoto Y, Gotoh M, Liu D, Kihara M, Kameyama K, et al. Slow release of bone morphogenetic protein 2 from a gelatin sponge to promote regeneration of tracheal cartilage in a canine model. J Thorac Cardiovasc Surg. 2004;127:329–34.PubMedCrossRefGoogle Scholar
- 9.Igai H, Yamamoto Y, Chang SS, Yamamoto M, Tabata Y, Yokomise H. Tracheal cartilage regeneration by slow release of basic fibroblast growth factor from a gelatin sponge. J Thorac Cardiovasc Surg. 2007;134:170–5.PubMedCrossRefGoogle Scholar
- 10.Misaki N, Yamamoto Y, Okamoto T, Chang SS, Igai H, Gotoh M, et al. Intra-thoracic fibrous tissue induction by polylactic acid and epsilon-caprolactone copolymer cubes, with or without slow release of basic fibroblast growth factor. Eur J Cardiothorac Surg. 2007;32:761–5.PubMedCrossRefGoogle Scholar
- 11.Igai H, Chang SS, Gotoh M, Yamamoto Y, Yamamoto M, Tabata Y, et al. Widespread and early tracheal cartilage regeneration by synchronous slow release of b-FGF and BMP-2. ASAIO J. 2009;55(3):266–70.PubMedCrossRefGoogle Scholar
- 12.Chang SS, Igai H, Misaki N, Gotoh M, Yamamoto Y, Tabata Y, et al. Closure of the pleural dead space after pneumonectomy in a rabbit model: use of bioabsorbable lactic acid and caprolactone copolymer cubes. ASAIO J. 2008;54(1):109–14.PubMedCrossRefGoogle Scholar
- 13.Gotoh M, Okamoto T, Yamamoto Y, Yokomise H. Real time imaging and quantitative evaluation of the emphysematous lung by infrared thoracoscopy in experimental dogs. ASAIO J. 2005;51(2):148–51.PubMedCrossRefGoogle Scholar
- 14.Mori N, Gotoh M, Chang SS, Igai H, Misaki N, Yamamoto Y, et al. Reconstruction of emphysematous lung tissue using slowly released basic fibroblast growth factor from gelatin microspheres. ASAIO J. 2008;54:622–6.PubMedCrossRefGoogle Scholar
- 15.Gillooly M, Lamb D, Farrow AS. New automated technique for assessing emphysema on histological sections. J Clin Pathol. 1991;44:1007–11.PubMedCentralPubMedCrossRefGoogle Scholar
- 16.Tabata Y, Hijikata S, Muniruzzaman M, Ikada Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed. 1999;10:79–94.PubMedCrossRefGoogle Scholar
- 17.Yamamoto M, Ikada Y, Tabata Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed. 2001;12:77–88.PubMedCrossRefGoogle Scholar
- 18.Hiraoka Y, Yamashiro H, Yasuda K, Kimura Y, Inamoto T, Tabata Y. In situ regeneration of adipose tissue in rat fat pad by combining a collagen scaffold with gelatin microspheres containing basic fibroblast growth factor. Tissue Eng. 2006;12:1475–87.PubMedCrossRefGoogle Scholar
- 19.Iwakura A, Fujita M, Tabata Y. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels. 2003;18:93–9.PubMedCrossRefGoogle Scholar
- 20.Sakakibara Y, Tabata Y, Komeda M. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg. 2002;124:50–6.PubMedCrossRefGoogle Scholar
- 21.Sakakibara Y, Tambara K, Sakaguchi G, Lu F, Yamamoto M, Nishimura K, et al. Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg. 2003;24:105–11.PubMedCrossRefGoogle Scholar
- 22.Nakajima H, Sakakibara Y, Tambara K, Iwakura A, Marui A, et al. Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury: toward safety and minimal invasiveness. J Artif Organs. 2004;7:58–61.PubMedCrossRefGoogle Scholar
- 23.Morino S, Toba T, Tao H, Araki M, Shimizu Y, Nakamura T, et al. Fibroblast growth factor-2 promotes recovery of pulmonary function in a canine models of elastase-induced emphysema. Exp Lung Res. 2007;33:15–26.PubMedCrossRefGoogle Scholar
- 24.Morino S, Nakamura T, Toba T, Takahashi M, Kushibiki T, Tabata Y, et al. Fibroblast growth factor-2 induces recovery of pulmonary blood flow in canine emphysema models. Chest. 2005;128:920–6.PubMedCrossRefGoogle Scholar